Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Fibrinolysis

Citations 11-20 of 146 total displayed.

Past content (since Jan 1999):

Controversies in Cardiovascular Medicine
Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction
Paul W. Armstrong, Cynthia M. Westerhout, and Robert C. Welsh
Circulation 2009;119:1293-1303, doi:10.1161/CIRCULATIONAHA.108.796383 [Full text]  

Controversies in Cardiovascular Medicine
Duration of Symptoms Is Not Always the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction
Peter Bogaty
Circulation 2009;119:1304-1310, doi:10.1161/CIRCULATIONAHA.107.750679 [Full text]  

Coronary Heart Disease
Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period
Jaume Figueras, Oscar Alcalde, José A. Barrabés, Vicens Serra, Joan Alguersuari, Josefa Cortadellas, and Rosa-Maria Lidón
Circulation 2008;118:2783-2789; published online before print as doi:10.1161/CIRCULATIONAHA.108.776690 [Abstract] [Full text]  

Articles
Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period
Jaume Figueras, Oscar Alcalde, José A. Barrabés, Vicens Serra, Joan Alguersuari, Josefa Cortadellas, and Rosa-Maria Lidón
Circulation published December 8, 2008, doi:10.1161/CIRCULATIONAHA.108.776690 [Abstract]  

Images in Cardiovascular Medicine
Regression of Thrombus and Electrocardiographic Changes With Thrombolytic Therapy in Acute Massive Pulmonary Embolism
Evin Bozcali and Yildiray Tutpinar
Circulation 2008;118:2207-2208, doi:10.1161/CIRCULATIONAHA.108.780601 [Full text]  

Editorials
A Novel Role for Tissue-Type Plasminogen Activator: Prevention of Thromboembolic Occlusion
David J. Schneider and Burton E. Sobel
Circulation 2008;118:1408-1409, doi:10.1161/CIRCULATIONAHA.108.807586 [Full text]  

Stroke
Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator
Kristina Danielyan, Kumkum Ganguly, Bi-Sen Ding, Dmitriy Atochin, Sergei Zaitsev, Juan-Carlos Murciano, Paul L. Huang, Scott E. Kasner, Douglas B. Cines, and Vladimir R. Muzykantov
Circulation 2008;118:1442-1449; published online before print as doi:10.1161/CIRCULATIONAHA.107.750257 [Abstract] [Full text]  

The 2008 World Congress of Cardiology Abstracts, Buenos Aires, Argentina, May 18-21, 2008
2008 WCC Poster Presentations
Circulation 2008;118:e162-413e; published online before print as doi:10.1161/CIRCULATIONAHA.108.189874 [PDF]  

The 2008 World Congress of Cardiology Abstracts, Buenos Aires, Argentina, May 18-21, 2008
2008 WCC Oral Presentations
Circulation 2008;118:e414-491e; published online before print as doi:10.1161/CIRCULATIONAHA.108.189875 [PDF]  

Images in Cardiovascular Medicine
Young Adult With Congenital Heart Disease Presenting With Anasarca
Riet Dierckx, Steven E. Haine, Christiaan J. Vrints, and Bernard P. Paelinck
Circulation 2008;118:1304-1305, doi:10.1161/CIRCULATIONAHA.108.767632 [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

* Subspecialty Collections Home

* Show  Fibrinolysis
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors